Go to Publication
Continue Reading
Resistance to second-line drugs in multidrug-resistant tuberculosis.
Go to Publication
Continue Reading
Early bactericidal activity of new drug regimens for tuberculosis.
Go to Publication
Continue Reading
The added effect of thioridazine in the treatment of drug-resistant tuberculosis.
Go to Publication
Continue Reading
Totally drug-resistant tuberculosis in India: who let the djinn out?
Abstract BACKGROUND: Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on…
Continue Reading
Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.
Abstract RATIONALE: Volatile organic compounds (VOCs) in breath provide biomarkers of tuberculosis (TB) because Mycobacterium tuberculosis manufactures VOC metabolites that are detectable in the breath of infected patients.…
Continue Reading
Point-of-care breath test for biomarkers of active pulmonary tuberculosis.
Go to Publication
Continue Reading
MDR, XDR, TDR tuberculosis: ominous progression.
Go to Publication
Continue Reading
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
Go to Publication
Continue Reading
Disseminated tuberculosis with immune thrombocytopenic purpura.
Go to Publication
Continue Reading
Totally drug-resistant tuberculosis in India.
- Go to the previous page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- …
- 17
- Go to the next page